Gainers:
- ImmunoGen (+83%): Consolidation in the pharmaceutical sector continues! US drugmaker ImmunoGen has agreed to be acquired by research-based pharmaceutical specialist AbbVie for $10.1 billion. AbbVie has thus strengthened its portfolio of cancer treatments, notably by acquiring Elahere, a blockbuster drug approved for ovarian cancer. The transaction is expected to close in mid-2024.
- Affirm (+31%): The US specialist in deferred payment and e-commerce solutions is riding on the momentum generated by the Black Friday and Cyber Monday shopping holidays. The use of BNPL (Buy Now, Pay Later) systems in the US hit a record high on Monday, with $940 million spent online, up 42.5% on the previous year. In the wake of this, Jefferies raised its recommendation on the stock.
- PDD Holdings (+24%): The parent company of Pinduoduo, the US-listed Chinese e-commerce giant, is doing much better than expected. Quarterly revenues were up 94%, exceeding analysts' forecasts by over $2 billion, and net income was up 37%. These results were underpinned, among other things, by the recovery of the Chinese economy and the fine performance of Temu, an international marketplace that is a big hit on app stores.
- Rolls-Royce (+14%): The British aircraft engine manufacturer maintained its forecasts for fiscal 2023, expecting operating profit of between 1.2 and 1.4 billion pounds, and presented its medium-term financial objectives (2027-2028). These include an increase in operating margin to 13%-15% and the disposal of 1 to 1.5 billion pounds worth of assets. Among other things, the Group plans to withdraw from Rolls-Royce Electric, its flying cab and electric aircraft business.
- Salesforce (+12%): The American software company is doing well. Last quarter, revenues (up 11%) and profits exceeded expectations, driven by the services division. The company also published an encouraging outlook for the fourth quarter (forecasting 10% revenue growth) and raised its full-year targets for the second time this year. Many analysts, including Morgan Stanley, Evercore, Wells Fargo and Deutsche Bank, have raised their price target on the stock.
- General Motors (+12%): Four pieces of good news for investors in the American carmaker. Firstly, the group has decided to pamper its shareholders by increasing its dividend by 33% in 2024 and by carrying out an accelerated share buyback of $10 billion. Secondly, it has announced that it is halting the activities of Cruise, its autonomous driving and robot-taxi subsidiary, in the United States after a series of accidents. This will save money and finance the wage increases promised after strikes in the sector. The group is also expecting solid profits this year, and has announced that it has won a 10-year production contract from the US State Department for the delivery of an armored SUV.
- Snap (+10%): Shares in social network Snapchat surged on the back of a change in recommendation by Jefferies, which raised its rating on the stock from neutral to buy and its price target from $12 to $16. The analyst praised the platform's efforts to improve profitability and advertising revenues, as well as its partnership with Amazon. As a reminder, last month the group unveiled a surprise adjusted quarterly profit and an increase in daily active users. The share price has risen by 54% since the start of the year.
Losers:
- Dr. Martens (-13%): The British brand of leather boots is struggling. Sales in the United States and Asia are down sharply (-18% and 10%), despite new store openings, which cannot be offset by the brand's good health in Europe. As a result, this week the Group issued its fourth profit warning in 12 months, and cancelled its revenue forecasts for fiscal 2025.
- Jabil (-12%): The US electronics manufacturing solutions provider has lowered its revenue outlook for the current quarter and financial year, due to lower demand. It now expects sales of $8.3 to $8.4 billion for the first quarter and $31 billion for the full year, below analysts' expectations.
- Pure storage (-10%): The US technology company specializing in data storage disappointed. Quarterly sales rose by 12.8%, but fell short of analysts' expectations, who also deplored the company's timid forecasts for the next quarter and the full year. As a result, several analysts have revised their recommendations downwards.
|